Read on Twitter
Exclusive:
I’d asked the Modi govt for clinical trial, safety, & efficacy data of Bharat Biotech’s Covaxin based on which it was approved.
The govt refused to disclose it on the grounds that “disclosure would harm the competitive position of Bharat Biotech”.
WHAT IS GOING ON?
I’d asked the Modi govt for clinical trial, safety, & efficacy data of Bharat Biotech’s Covaxin based on which it was approved.
The govt refused to disclose it on the grounds that “disclosure would harm the competitive position of Bharat Biotech”.
WHAT IS GOING ON?
Clinical trial, safety, & efficacy data of a vaccine is PUBLIC INFORMATION globally. It’s the only way of evaluating it & being reassured that the vaccine is legit.
It is NOT any confidential formula.
Why would disclosure affect Bharat Biotech’s “competitive position”?
It is NOT any confidential formula.
Why would disclosure affect Bharat Biotech’s “competitive position”?
The ONLY reason Bharat Biotech’s competitive position would be harmed by release of clinical trial, safety, & efficacy data is if the data shows the vaccine is inferior or if the data doesn’t match the claims made by the govt & the company.
What are you hiding, @drharshvardhan?
What are you hiding, @drharshvardhan?
